The brief overview, antivirus and anti-SARS-CoV-2 activity, quantitative methods, and pharmacokinetics of cepharanthine: a potential small-molecule drug against COVID-19

The brief overview, antivirus and anti-SARS-CoV-2 activity, quantitative methods, and pharmacokinetics of cepharanthine: a potential small-molecule drug against COVID-19

To effectively respond to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), an increasing number of researchers are focusing on the antiviral activity of cepharanthine (CEP), which is a clinically approved drug being used for over 70 years. This review aims to provide a brief overview of...

Full description

Bibliographic Details
Main Authors: Binbin Xia, Li Zheng, Yali Li, Wenfang Sun, Yang Liu, Liushui Li, Jingyao Pang, Jing Chen, Jiaxin Li, Hua Cheng
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-07-01
Series:Frontiers in Pharmacology
Subjects:
cepharanthine
antivirus
anti-SARS-CoV-2
pharmacokinetics
research progress
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1098972/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2023.1098972/full

Similar Items